Covered recipient · General Payments record
LAN JAMESON CROFTON
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2025
$2,002.47
- Reported across 30 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $994.17 | 14 |
| Education | $12.42 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $287.09 | 6 |
| TACTILE SYSTEMS TECHNOLOGY INC | $149.79 | 1 |
| Galderma Laboratories, L.P. | $146.81 | 1 |
| Lilly USA, LLC | $140.19 | 3 |
| DEXCOM, INC. | $127.71 | 1 |
| Janssen Biotech, Inc. | $105.95 | 1 |
| UCB, Inc. | $27.42 | 1 |
| ViiV Healthcare Company | $21.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Dexcom, Inc. | $127.71 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250568552 | CMS |
| Galderma Laboratories, L.P. | $146.81 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234746364 | CMS |
| Gilead Sciences, Inc. | $28.68 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234446819 | CMS |
| Gilead Sciences, Inc. | $120.79 | 04/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234390250 | CMS |
| Gilead Sciences, Inc. | $83.85 | 05/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234406623 | CMS |
| Gilead Sciences, Inc. | $15.14 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234571256 | CMS |
| Gilead Sciences, Inc. | $12.42 | 08/28/2025 | Education | Undisputed | 06/30/2026 | 1234362737 | CMS |
| Gilead Sciences, Inc. | $26.21 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234464421 | CMS |
| Janssen Biotech, Inc. | $105.95 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174320307 | CMS |
| Lilly USA, LLC | $0.20 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187161467 | CMS |
| Lilly USA, LLC | $15.00 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187208861 | CMS |
| Lilly USA, LLC | $124.99 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187139461 | CMS |
| Tactile Systems Technology Inc | $149.79 | 05/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1180551852 | CMS |
| UCB, Inc. | $27.42 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224637501 | CMS |
| ViiV Healthcare Company | $21.63 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189515994 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.